O
Ole Wichmann
Researcher at Robert Koch Institute
Publications - 228
Citations - 7533
Ole Wichmann is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: Vaccination & Population. The author has an hindex of 43, co-authored 200 publications receiving 6223 citations. Previous affiliations of Ole Wichmann include Ludwig Maximilian University of Munich & Humboldt University of Berlin.
Papers
More filters
Journal ArticleDOI
Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany.
TL;DR: In this article, the authors conducted a survey among pregnant women in Germany to assess knowledge, attitudes, and practices related to influenza vaccination during pregnancy and to identify factors associated with their pertussis vaccination status.
Journal ArticleDOI
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.
Marina Treskova-Schwarzbach,Laura Haas,Sarah Reda,Antonia Pilic,Anna Borodova,Kasra Karimi,Judith Koch,Teresa Nygren,Stefan Scholz,Viktoria Schönfeld,Sabine Vygen-Bonnet,Ole Wichmann,Thomas Harder +12 more
TL;DR: In this paper, the authors applied an umbrella review approach to summarise the global evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health conditions.
Journal ArticleDOI
Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study
TL;DR: Estimating influenza vaccination uptake for the 2012/13 and 2013/14 seasons, assessing knowledge and attitudes about influenza vaccination, and identifying factors associated with vaccination uptake in two risk groups are aimed at.
Journal ArticleDOI
Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis
TL;DR: Due to strong residual confounding in most of the identified studies, the available evidence is insufficient to determine the magnitude of benefit that diabetic people derive from seasonal influenza vaccination.
Journal ArticleDOI
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021.
Thomas Harder,Judith Koch,Sabine Vygen-Bonnet,Wiebe Külper-Schiek,Antonia Pilic,Sarah Reda,Stefan Scholz,Ole Wichmann +7 more
TL;DR: In this paper, the authors report interim results of a living systematic review that identified a total of 30 studies that investigated VE against symptomatic and/or asymptomatic infection.